BeStock  

BioLife Solutions BLFS

US equityMarket cap rank #2708Medical Instruments & Supplies
$0.00 +$0.00 (0.00%)
Market closed · Oct 22, 12:40 am ET
Open$0.00
Prev close$0.00
Day range$0.00 – $0.00
Volume0.00
Market cap$1.89B
P/E (TTM)32.7
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$28.47M+21.5% YoY
Operating profit$1.70M+110.5% YoY
Net profit$45.10M+384.8% YoY
Diluted EPS$0.91+375.8% YoY
Free cash flow$5.19M-7.8% YoY
Operating cash flow$6.35M

Revenue, last 8 quarters

$21.4MSep '24$15.1MDec '24$22.1MMar '25$23.4MJun '25$28.1MSep '25$18.8MDec '25$27.5MMar '26$28.5MJun '26

Net profit, last 8 quarters

$-1.7MSep '24$12.5MDec '24$-448.0KMar '25$-15.8MJun '25$621.0KSep '25$11.1MDec '25$1.2MMar '26$45.1MJun '26

Diluted EPS by quarter

-0.04Sep '240.26Dec '24-0.01Mar '25-0.33Jun '250.01Sep '250.22Dec '250.02Mar '260.91Jun '26

Free cash flow by quarter

$3.7MSep '24$583.0KDec '24$1.6MMar '25$5.6MJun '25$2.8MSep '25$-9.6MDec '25$-658.0KMar '26$5.2MJun '26

Annual revenue

$48.1MFY20$119.2MFY21$76.2MFY22$68.0MFY23$74.6MFY24$96.2MFY25

Profitability & balance sheet

Gross margin63.6%
Operating margin1.6%
Net margin54.3%
Return on equity15.1%
Return on assets13.9%
Return on invested capital14.4%
Current ratio9.69
Liabilities / assets6.1%
Cash & investments$82.42M
Total debt$13.15M
Net cash (debt)$69.27M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $28.47M $27.50M $96.21M $18.79M $28.07M
Total Operating Revenue $28.47M $27.50M $96.21M $18.79M $28.07M
Cost of Revenue $10.18M $10.00M $34.10M $6.81M $10.15M
Gross Profit $18.29M $17.50M $62.12M $11.98M $17.92M
Operating Expense $16.59M $17.47M $78.72M $10.63M $18.01M
Selling and Admin Expenses $13.48M $14.73M $55.37M $12.54M $14.60M
-Selling & Marketing Expense $2.78M $2.53M $9.85M $1.99M $2.53M
-General & Admin Expense $10.69M $12.21M $45.52M $10.55M $12.07M
Research & Development $2.96M $2.65M $23.09M -$67,000.00 $2.71M
Depreciation & Amortization & Depletion $157,000.00 $85,000.00 $263,000.00 -$1.85M $699,000.00
-Depreciation & Amortization $157,000.00 $85,000.00 $263,000.00 -$1.85M $699,000.00
Operating Profit $1.70M $27,000.00 -$16.60M $1.35M -$89,000.00
Net Non-Operating Interest Income (Expense) $994,000.00 $1.04M $2.71M $833,000.00 $508,000.00
Non-Operating Interest Income $994,000.00 $1.04M – – –
Other Income (Expense) $63,000.00 $180,000.00 $1.82M $1.18M $284,000.00
Other Non-Operating Income (Expenses) $63,000.00 $180,000.00 $1.82M $1.18M $284,000.00
Pretax Profit $2.75M $1.25M -$12.08M $3.36M $703,000.00
Tax -$42.35M $62,000.00 $49,000.00 -$173,000.00 $82,000.00
Net Profit $45.10M $1.19M -$4.60M $11.07M $621,000.00
Profit from Continuing Operations $45.10M $1.19M -$12.13M $3.54M $621,000.00
Net Income from Discontinuous Operations $0.00 $0.00 $7.54M $7.54M $0.00
Net Income to Parent Company $45.10M $1.19M -$4.60M $11.07M $621,000.00
Net Income to Common Stockholders $45.10M $1.19M -$4.60M $11.07M $621,000.00
Basic EPS $0.92 $0.02 -$0.09 $0.23 $0.01
Diluted EPS $0.91 $0.02 -$0.10 $0.22 $0.01
Total Other Finance Costs – – -$2.71M -$833,000.00 -$508,000.00
Special Income (Charges) – – $0.00 – –
-Less:Restructuring and Mergern & Acquisition – – $0.00 – –

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $447.49M $400.91M $405.88M $405.88M $392.08M
Total Current Assets $135.20M $133.22M $136.56M $136.56M $126.57M
Cash and Cash Equivalents & Short-Term Investments $82.42M $81.00M $88.93M $88.93M $78.95M
-Cash and Cash Equivalents $24.00M $22.82M $33.04M $33.04M $29.48M
-Short Term Investments $58.42M $58.17M $55.89M $55.89M $49.47M
Receivables $10.65M $13.06M $7.95M $7.95M $10.84M
-Accounts Receivable $10.65M $13.06M $7.95M $7.95M $10.84M
Inventory $35.59M $32.83M $30.16M $30.16M $27.83M
Other Current Assets $6.54M $6.34M $9.53M $9.53M $8.95M
Total Non-Current Assets $312.30M $267.68M $269.32M $269.32M $265.52M
Net PPE $23.88M $21.62M $22.18M $22.18M $18.73M
-Gross PPE $29.65M $26.98M $27.11M $27.11M $23.68M
-Accumulated Depreciation -$5.77M -$5.36M -$4.93M -$4.93M -$4.95M
Investments and Advances $30.65M $30.50M $31.25M $31.25M $19.44M
-Available for Sale Securities $30.65M $30.50M $31.25M $31.25M $19.44M
Goodwill and Other Intangible Assets $212.24M $212.52M $212.84M $212.84M $219.75M
-Goodwill $208.59M $208.59M $208.59M $208.59M $212.30M
-Other Intangible Assets $3.65M $3.93M $4.26M $4.26M $7.45M
Non-Current Deferred Assets $42.23M – – – –
Other Non-Current Assets $3.29M $3.05M $3.05M $3.05M $7.58M
Total Liabilities $27.49M $28.68M $34.00M $34.00M $38.34M
Total Current Liabilities $13.95M $18.25M $22.98M $22.98M $27.15M
Payables $4.60M $5.95M $3.77M $3.77M $6.57M
-Accounts Payable $2.48M $3.75M $1.49M $1.49M $2.89M
-Total Tax Payable $2.12M $2.20M $2.28M $2.28M $3.68M
Current Accrued Expenses $2.70M $3.26M $5.85M $5.85M $5.91M
Short-Term Debt and Capital Lease Obligation $2.59M $4.82M $7.24M $7.24M $9.67M
-Current Capital Lease Obligation $2.59M $2.32M $2.24M $2.24M $2.18M
Current Deferred Liabilities $188,000.00 $206,000.00 $195,000.00 $195,000.00 $154,000.00
Total Non-Current Liabilities $13.54M $10.42M $11.02M $11.02M $11.20M
Long Term Debt and Capital Lease Obligation $13.15M $10.04M $10.66M $10.66M $11.01M
-Long Term Capital Lease Obligation $13.15M $10.04M $10.66M $10.66M $11.01M
Non-Current Deferred Liabilities $0.00 $198,000.00 $189,000.00 $189,000.00 $189,000.00
Other Non-Current Liabilities $399,000.00 $183,000.00 $171,000.00 $171,000.00 –
Total Equity $420.00M $372.23M $371.89M $371.89M $353.74M
Stockholders' Equity $420.00M $372.23M $371.89M $371.89M $353.74M
Capital Stock $49,000.00 $49,000.00 $48,000.00 $48,000.00 $48,000.00
-Common Stock $49,000.00 $49,000.00 $48,000.00 $48,000.00 $48,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $713.57M $710.81M $711.40M $711.40M $704.33M
Retained Earnings -$293.41M -$338.51M -$339.70M -$339.70M -$350.77M
Gains/Losses Not Affecting Retained Earnings -$211,000.00 -$120,000.00 $132,000.00 $132,000.00 $130,000.00
-Current Debt – $2.50M $5.00M $5.00M $7.49M
-Long Term Equity Investment – – $0.00 $0.00 $0.00

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $6.35M -$491,000.00 $20.12M $4.92M $6.10M
Net cash flow from continuing operations $6.35M -$491,000.00 $20.12M $4.92M $6.10M
Net Income from Continuing Operations $45.10M $1.19M -$4.60M $11.07M $621,000.00
Depreciation & Depletion & Amortization $809,000.00 $699,000.00 $4.69M $586,000.00 $1.34M
Deferred Tax -$42.43M $9,000.00 $65,000.00 $0.00 $14,000.00
Other Non-Cash Items $1.85M -$188,000.00 $17.40M -$118,000.00 $1.32M
Change in Working Capital -$2.76M -$6.88M -$8.91M -$2.24M -$2.99M
-Change in Receivables $2.41M -$5.10M $264,000.00 $1.94M -$782,000.00
-Change in Inventory -$2.76M -$2.68M -$1.27M -$2.33M -$197,000.00
-Change in Prepaid Assets -$246,000.00 $3.22M -$3.04M -$462,000.00 -$3.00M
-Change in Payables and Accrued Expense -$2.16M -$2.34M -$5.14M -$1.66M $990,000.00
-Change In Other Working Capital $0.00 $26,000.00 $264,000.00 – –
Net cash flow from investing -$1.58M -$1.83M -$71.54M $1.14M -$5.97M
Net Cash Flow from Continuing Investing Activities -$1.58M -$1.83M -$71.54M $1.14M -$5.97M
Net PPE Purchase and Sale -$1.04M -$167,000.00 -$9.48M -$4.26M -$3.30M
Net Investment Purchase and Sale -$416,000.00 -$1.66M -$74.47M -$18.02M -$2.29M
Financing Cash Flow -$3.59M -$7.90M -$10.92M -$2.50M -$2.56M
Net Cash Flow from Continuing Financing Activities -$3.59M -$7.90M -$10.92M -$2.50M -$2.56M
Net Issuance Payments Of Debt -$2.50M -$2.50M -$10.00M -$2.50M -$2.50M
Proceeds from Stock Option Exercised $3,000.00 $190,000.00 $18,000.00 $0.00 $0.00
Net Other Financing Charges -$1.10M -$5.59M -$942,000.00 $4,000.00 -$58,000.00
Ending Cash Balance $24.00M $22.82M $33.04M $33.04M $29.48M
Net Change in Cash $1.18M -$10.22M -$62.35M $3.56M -$2.42M
Beginning Cash Balance $22.82M $33.04M $95.39M $29.48M $31.90M
Free Cash Flow $5.19M -$658,000.00 $416,000.00 -$9.56M $2.80M
Gain/Loss from Continuing Operations – – -$9.80M -$10.31M $167,000.00
-Change in Other Current Liabilities – – $5,000.00 – –
Net Intangibles Purchase and Sale – – -$10.22M – –
Net Business Purchase and Sale – – $23.52M $33.74M $0.00
Net Other Investing Changes – – -$886,000.00 -$101,000.00 -$373,000.00
Net Common Stock Issuance – – $0.00 – –
Effect of Exchange Rate Changes – – $0.00 $0.00 –

Discussion

No comments yet — be the first to weigh in on BLFS.

Sign in to join the discussion.

Scroll to Top